Aggressive periodontitis (AP) is a multifactorial, severe, and rapidly progressive form of periodontitis that primarily affects younger patients. It is characterized by a unique set of clinical and microbiological features that distinguish it from other forms of periodontal disease.

Key Characteristics

• Rapid Progression: AP is marked by a swift deterioration of periodontal tissues.
• Age Group: Primarily affects adolescents and young adults, but can occur at any age.
• Multifactorial Etiology: Involves a combination of microbiological, immunological, genetic, and environmental factors.

Other Findings

• Presence of Aggregatibacter actinomycetemcomitans (A.a.) in diseased sites.
• Abnormal host responses, including impaired phagocytosis and chemotaxis.
• Hyperresponsive macrophages leading to exaggerated inflammatory responses.
• The disease may exhibit self-arresting tendencies in some cases.

Classification

Aggressive periodontitis can be classified into two main types:

1. Localized Aggressive Periodontitis (LAP): Typically affects the permanent molars and incisors, often with localized attachment loss.
2. Generalized Aggressive Periodontitis (GAP): Involves more widespread periodontal tissue destruction.

Risk Factors

Microbiological Factors

• Aggregatibacter actinomycetemcomitans: A primary pathogen associated with LAP, producing a potent leukotoxin that kills neutrophils.
• Different strains of A.a. produce varying levels of leukotoxin, with highly toxic strains more prevalent in affected individuals.

Immunological Factors

• Human Leukocyte Antigens (HLAs): HLA-A9 and B-15 are candidate markers for aggressive periodontitis.
• Defective neutrophil function leads to impaired chemotaxis and phagocytosis.
• Hyper-responsive macrophage phenotype, characterized by elevated levels of PGE2 and IL-1β, may contribute to connective tissue breakdown and bone loss.

Genetic Factors

• Familial clustering of neutrophil abnormalities suggests a genetic predisposition.
• Genetic control of antibody responses to A.a., with variations in the ability to produce protective IgG2 antibodies.

Environmental Factors

• Smoking is a significant risk factor, with smokers experiencing more severe periodontal destruction compared to non-smokers.

Treatment Approaches

General Considerations

• Treatment strategies depend on the type and extent of periodontal destruction.
• GAP typically has a poorer prognosis compared to LAP, as it is less likely to enter spontaneous remission.

Conventional Periodontal Therapy

• Patient Education: Informing patients about the disease and its implications.
• Oral Hygiene Instructions: Reinforcing proper oral hygiene practices.
• Scaling and Root Planing: Removal of plaque and calculus to control local factors.

Surgical Resection Therapy

• Aimed at reducing or eliminating pocket depth.
• Contraindicated in cases of severe horizontal bone loss due to the risk of increased tooth mobility.

Regenerative Therapy

• Potential for regeneration is promising in AP cases.
• Techniques include open flap surgical debridement, root surface conditioning with tetracycline, and the use of allogenic bone grafts.
• Recent advances involve the use of enamel matrix proteins to promote cementum regeneration and new attachment.

Antimicrobial Therapy

• Often required as adjunctive treatment to eliminate A.a. from periodontal tissues.
• Tetracycline: Administered in various regimens to concentrate in periodontal tissues and inhibit A.a. growth.
• Combination Therapy: Metronidazole combined with amoxicillin has shown efficacy alongside periodontal therapy.
• Doxycycline: Used at a dose of 100 mg/day.
• Chlorhexidine (CHX): Irrigation and home rinsing to control bacterial load.

Host Modulation

• Involves the use of sub-antimicrobial dose doxycycline (SDD) to prevent periodontal attachment loss by modulating the activity of matrix metalloproteinases (MMPs), particularly collagenase and gelatinase.

• Scaling in 2 appointments within 24 hours
• Tongue brushing with 1% chlorhexidine gel
• 0.2% chlorhexidine rinse
• 1% chlorhexidine pocket irrigation

Oral Hygiene Tools

Toothbrush Bristle Diameter:

• Soft: 0.007" (0.2 mm)
• Medium: 0.012" (0.3 mm)
• Hard: 0.014" (0.4 mm)

Brushing Techniques:

• Roll: Modified Stillman
• Circular: Fones
• Vertical: Leonard
• Horizontal: Scrub

Scaling Instruments

• Gracey curettes: Only outer cutting edge
• Universal curettes: Both edges cutting
• Langer curettes: Gracey shank + Universal blade
• Best grasp: Modified pen grasp (tripod effect)
• Scaling angle: 45 – 90°

Ultrasonic Scaling

• Vibration frequency: 18,000 – 50,000 cycles/sec

Stroke Types

• Exploratory: Light feeling (with probes)
• Scaling: Short powerful pull
• Root planing: Moderate to light pull

Fundamental Concepts

1. Primary Plaque Retentive Factor: Calculus provides rough surface for bacterial adherence
2. Calculus Formation Inhibitor: Pyrophosphate in toothpaste formulations
3. Optimal Graft Conditions: Three-walled defects offer best regenerative potential
4. Highest Osteogenic Potential: Autogenous cancellous bone grafts

Diagnostic Standards

5. Halitosis Gold Standard: Organoleptic analysis (human nose assessment)
6. Furcation Vulnerability: Most susceptible to trauma from excessive occlusal forces
7. Worst Furcation Prognosis: Maxillary first premolar due to root proximity

Risk Factors and Prevention

8. Leading Cause of Recession: Traumatic toothbrushing techniques
9. Root Caries Organism: Actinomyces viscosus
10. Most Preventable Risk Factor: Smoking cessation offers greatest improvement in treatment outcomes

🔬 Key Features & Forms

• Most infective form: Cavitary lesion
• Primary TB Presentation: Unilateral hilar lymphadenopathy
• Rich focus: Meninges (associated with TB meningitis)
• Cavitation: Absent in HIV-associated or primary TB

💡 Special Manifestations

• Hypersensitivity to Mycobacteria: Phlyctenular conjunctivitis
• Poncet’s disease: Joint pains without active arthritis
• Miliary TB: Mantoux test negative
• Recurrent hemoptysis source: Bronchial artery

💊 Drug Details

• Streptomycin: Not used in TB meningitis
• Bedaquiline: New drug for MDR-TB

Components of Gingival Crevicular Fluid (GCF) and Matrix Metalloproteinases (MMPs)

Gingival crevicular fluid (GCF) is a serum-like fluid found in the gingival sulcus that plays a significant role in periodontal health and disease. Understanding its composition, particularly glucose and protein content, as well as the role of matrix metalloproteinases (MMPs) in tissue remodeling, is essential for dental professionals.

Composition of Gingival Crevicular Fluid (GCF)

1. Glucose and Hexosamines:

   • GCF contains compounds such as glucose, hexosamines, and hexuronic acid.
   • Glucose Levels:
     • Blood glucose levels do not correlate with GCF glucose levels; in fact, glucose concentration in GCF is three to four times greater than that in serum.
     • This elevated glucose level is interpreted as a result of the metabolic activity of adjacent tissues and the influence of local microbial flora.

2. Protein Content:

   • The total protein content of GCF is significantly less than that of serum.
   • This difference in protein concentration reflects the unique environment of the gingival sulcus and the specific functions of GCF in periodontal health.

Matrix Metalloproteinases (MMPs)

1. Definition and Function:

   • MMPs are a family of proteolytic enzymes that degrade extracellular matrix molecules, including collagen, gelatin, and elastin.
   • They are produced by various cell types, including:
     • Neutrophils
     • Macrophages
     • Fibroblasts
     • Epithelial cells
     • Osteoblasts and osteoclasts

2. Classification:

   • MMPs are classified based on their substrate specificity, although it is now recognized that many MMPs can degrade multiple substrates. The classification includes:
     • Collagenases: e.g., MMP-1 and MMP-8 (break down collagen)
     • Gelatinases: Type IV collagenases
     • Stromelysins
     • Matrilysins
     • Membrane-type metalloproteinases
     • Others

3. Activation and Inhibition:

   • MMPs are secreted in an inactive form (latent) and require proteolytic cleavage for activation. This activation is facilitated by proteases such as cathepsin G produced by neutrophils.
   • Inhibitors: MMPs are regulated by proteinase inhibitors, which possess anti-inflammatory properties. Key inhibitors include:
     • Serum Inhibitors:
       • α1-antitrypsin
       • α2-macroglobulin (produced by the liver, inactivates various proteinases)
     • Tissue Inhibitors:
       • Tissue inhibitors of metalloproteinases (TIMPs), with TIMP-1 being particularly important in periodontal disease.
   • Antibiotic Inhibition: MMPs can also be inhibited by tetracycline antibiotics, leading to the development of sub-antimicrobial formulations of doxycycline as a systemic adjunctive treatment for periodontitis, exploiting its anti-MMP properties.

Merkel Cells

1. Location and Function:
   • Merkel cells are located in the deeper layers of the epithelium and are associated with nerve endings.
   • They are connected to adjacent cells by desmosomes and are identified as tactile receptors.
   • These cells play a role in the sensation of touch and pressure, contributing to the sensory functions of the oral mucosa.

Clinical Implications

1. GCF Analysis:

   • The composition of GCF, including glucose and protein levels, can provide insights into the inflammatory status of the periodontal tissues and the presence of periodontal disease.

2. Role of MMPs in Periodontal Disease:

   • MMPs are involved in the remodeling of periodontal tissues during inflammation and disease progression. Understanding their regulation and activity is crucial for developing therapeutic strategies.

3. Therapeutic Applications:

   • The use of sub-antimicrobial doxycycline as an adjunctive treatment for periodontitis highlights the importance of MMP inhibition in managing periodontal disease.

4. Sensory Function:

   • The presence of Merkel cells in the gingival epithelium underscores the importance of sensory feedback in maintaining oral health and function.

Pathogens Implicated in Periodontal Diseases

Periodontal diseases are associated with a variety of pathogenic microorganisms. Below is a list of key pathogens implicated in different forms of periodontal disease, along with their associations:

General Pathogens Associated with Periodontal Diseases

• Actinobacillus actinomycetemcomitans:

  • Strongly associated with destructive periodontal disease.

• Porphyromonas gingivalis:

  • A member of the "black pigmented Bacteroides group" and a significant contributor to periodontal disease.

• Bacteroides forsythus:

  • Associated with chronic periodontitis.

• Spirochetes (Treponema denticola):

  • Implicated in various periodontal conditions.

• Prevotella intermedia/nigrescens:

  • Also belongs to the "black pigmented Bacteroides group" and is associated with several forms of periodontal disease.

• Fusobacterium nucleatum:

  • Plays a role in the progression of periodontal disease.

• Campylobacter rectus:

  • These organisms include members of the new genus Wolinella and are associated with periodontal disease.

Principal Bacteria Associated with Specific Periodontal Diseases

1. Adult Periodontitis:

   • Porphyromonas gingivalis
   • Prevotella intermedia
   • Bacteroides forsythus
   • Campylobacter rectus

2. Refractory Periodontitis:

   • Bacteroides forsythus
   • Porphyromonas gingivalis
   • Campylobacter rectus
   • Prevotella intermedia

3. Localized Juvenile Periodontitis (LJP):

   • Actinobacillus actinomycetemcomitans
   • Capnocytophaga

4. Periodontitis in Juvenile Diabetes:

   • Capnocytophaga
   • Actinobacillus actinomycetemcomitans

5. Pregnancy Gingivitis:

   • Prevotella intermedia

6. Acute Necrotizing Ulcerative Gingivitis (ANUG):

   • Prevotella intermedia
   • Intermediate-sized spirochetes